Virtus LifeSci Biotech Products ETF Rating → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free BBP Stock Alerts $56.68 -0.16 (-0.28%) (As of 05/16/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy2.73Holdings in BBP have an aggregate rating of Moderate Buy based on 596 analyst ratings issued in the past year covering 50 companies (98.4% of the portfolio).BBP Aggregate Price Target$84.0048.20% UpsideHigh Prediction$127.91Average Prediction$84.00Low Prediction$59.88Holdings in BBP have an aggregate price target of $84.00 and a range of $59.88 to $127.91 covering 50 companies (98.4% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.41%TARSTarsus Pharmaceuticals$38.58+0.2%4 of 5 stars2.88$50.38 30.6%8Analyst Revision3.31%ADMAADMA Biologics$9.06-0.4%3 of 5 stars3.25$10.50 15.9%4Short Interest ↑3.21%DCPHDeciphera Pharmaceuticals$25.453 of 5 stars2.30$24.17 -5.0%102.90%AGIOAgios Pharmaceuticals$35.00-0.5%2 of 5 stars2.50$35.00 0.0%42.78%SRPTSarepta Therapeutics$132.74+0.2%4 of 5 stars2.86$161.81 21.9%14Analyst UpgradePositive News2.71%SWTXSpringWorks Therapeutics$44.77-1.0%2 of 5 stars3.00$68.83 53.7%6Positive News2.60%MRNAModerna$132.68+2.8%3 of 5 stars2.24$126.46 -4.7%17Analyst Forecast2.55%LXRXLexicon Pharmaceuticals$1.84-5.2%2 of 5 stars2.67$5.00 171.7%3Short Interest ↑2.48%PTCTPTC Therapeutics$34.03+1.1%2 of 5 stars1.92$33.67 -1.1%132.36%NBIXNeurocrine Biosciences$141.91-0.1%5 of 5 stars2.79$148.96 5.0%24Analyst ForecastInsider SellingPositive News2.35%ASNDAscendis Pharma A/S$122.80-1.0%1 of 5 stars2.88$176.88 44.0%8Analyst Forecast2.28%KNSAKiniksa Pharmaceuticals$20.11+0.0%2 of 5 stars3.00$31.00 54.2%4Short Interest ↑2.27%BPMCBlueprint Medicines$106.64-0.1%1 of 5 stars2.53$102.65 -3.7%17Analyst ForecastShort Interest ↑Analyst Revision2.23%ITCIIntra-Cellular Therapies$66.53-0.5%5 of 5 stars2.90$90.17 35.5%10Positive News2.12%LGNDLigand Pharmaceuticals$85.02-0.9%5 of 5 stars3.00$116.33 36.8%3Insider Selling2.07%REGNRegeneron Pharmaceuticals$967.98-1.0%4 of 5 stars2.71$989.36 2.2%21Analyst ForecastInsider Selling2.05%AXSMAxsome Therapeutics$77.35+1.9%4 of 5 stars2.92$121.92 57.6%132.02%AMGNAmgen$314.72-1.4%5 of 5 stars2.52$305.65 -2.9%21Options Volume2.02%ROIVRoivant Sciences$11.41-0.8%3 of 5 stars2.90$16.90 48.1%10News CoveragePositive News2.01%UTHRUnited Therapeutics$272.22-0.2%5 of 5 stars2.90$308.78 13.4%10Analyst UpgradeInsider Selling2.00%HALOHalozyme Therapeutics$45.39-0.9%5 of 5 stars2.83$53.14 17.1%61.98%VRTXVertex Pharmaceuticals$440.64+0.7%4 of 5 stars2.48$432.18 -1.9%251.93%RYTMRhythm Pharmaceuticals$39.17-1.1%3 of 5 stars2.83$54.33 38.7%61.89%RAREUltragenyx Pharmaceutical$42.61+3.6%4 of 5 stars2.92$87.85 106.2%12Positive News1.89%EXELExelixis$21.23+0.5%5 of 5 stars2.59$26.13 23.1%17Analyst ForecastInsider SellingShort Interest ↑1.85%IMCRImmunocore$54.25-3.1%2 of 5 stars2.87$81.85 50.9%15Short Interest ↑1.80%HRMYHarmony Biosciences$29.31-1.3%4 of 5 stars2.50$40.63 38.6%8Positive News1.78%INSMInsmed$25.10+0.7%5 of 5 stars3.00$44.71 78.1%14Analyst ForecastInsider SellingShort Interest ↓Analyst Revision1.77%APLSApellis Pharmaceuticals$42.00+0.2%5 of 5 stars2.87$76.67 82.5%15Options VolumeAnalyst Revision1.73%IONSIonis Pharmaceuticals$37.62-4.1%5 of 5 stars2.71$59.54 58.3%14Short Interest ↓High Trading Volume1.73%BNTXBioNTech$92.98+0.8%2 of 5 stars2.27$117.25 26.1%10Analyst ForecastShort Interest ↑1.71%CRSPCRISPR Therapeutics$55.67-2.3%3 of 5 stars2.35$73.93 32.8%17Gap Up1.71%BMRNBioMarin Pharmaceutical$76.97-4.3%5 of 5 stars2.65$107.79 40.0%20Analyst ForecastShort Interest ↑Analyst RevisionHigh Trading Volume1.69%BIIBBiogen$230.04-2.2%5 of 5 stars2.65$288.46 25.4%26Analyst ForecastNews CoveragePositive News1.68%FOLDAmicus Therapeutics$9.50-1.7%4 of 5 stars2.86$17.50 84.2%7Analyst UpgradeShort Interest ↓1.67%BGNEBeiGene$171.03+3.7%3 of 5 stars2.80$251.93 47.3%10Gap Up1.66%INCYIncyte$56.86-0.3%5 of 5 stars2.47$74.93 31.8%17Short Interest ↑1.61%TBPHTheravance Biopharma$9.60-2.5%2 of 5 stars3.00$20.50 113.5%2Analyst Forecast1.61%GILDGilead Sciences$67.86+1.3%5 of 5 stars2.35$83.69 23.3%171.61%ALNYAlnylam Pharmaceuticals$151.22+2.6%4 of 5 stars2.59$216.19 43.0%17Short Interest ↑1.51%BBIOBridgeBio Pharma$31.04+3.6%5 of 5 stars2.91$48.00 54.6%11Analyst ForecastShort Interest ↑News Coverage1.49%MIRMMirum Pharmaceuticals$24.75-1.0%5 of 5 stars3.10$49.73 100.9%101.44%LEGNLegend Biotech$46.37+1.3%2 of 5 stars2.92$82.74 78.4%12Earnings ReportAnalyst ForecastAnalyst Revision1.44%IRWDIronwood Pharmaceuticals$6.64+1.2%4 of 5 stars3.00$18.40 177.1%5Short Interest ↓1.43%BCRXBioCryst Pharmaceuticals$6.47+1.7%4 of 5 stars3.00$14.00 116.4%7Insider Buying1.39%TVTXTravere Therapeutics$6.69-1.6%1 of 5 stars2.64$16.69 149.5%14Gap Up1.26%SAGESage Therapeutics$12.01+2.6%4 of 5 stars2.12$37.67 213.6%171.22%ACADACADIA Pharmaceuticals$14.85-1.8%4 of 5 stars2.75$28.94 94.9%16Short Interest ↑1.15%AUPHAurinia Pharmaceuticals$5.77+8.7%3 of 5 stars2.75$10.00 73.3%4Short Interest ↓Positive News1.06%ZLABZai Lab$19.93-4.4%2 of 5 stars3.00$64.22 222.2%5Insider Selling This page (NYSEARCA:BBP) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
